Systemic corticosteroid monotherapy using prednisone is not effective for patients with acute rhinosinusitis, according to a new study published in the August 7 issue of the Canadian Medical Association Journal.
Systemic corticosteroid monotherapy using prednisone is not effective for patients with acute rhinosinusitis, according to a new study.
Led by Roderick P. Venekamp, in conjunction with the Julius Center for Health Sciences and Primary Care in Utrecht, The Netherlands, the study was published in the August 7 issue of the Canadian Medical Association Journal.
Venekamp and colleagues conducted a block-randomized, double-blind, placebo-controlled clinical trial at 54 primary care practices in the Netherlands over a span of three years.
Of the 174 patients included in the trial, those with facial pain or pressure on day 7 were 62.5% in the prednisone group and 55.8% in the placebo group. “The groups were similar with regard to the decrease over time in the proportion of patients with total symptoms and health-related quality of life,” the researchers wrote.
“Our study results indicate that the anti-inflammatory effect of corticosteroids seems to be of no benefit in the broad population of patients with clinically diagnosed acute rhinosinusitis,” the researchers added.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.